A number of prescription drugs, like copyright and Semaglutide, are part of the GLP-1 category . Primarily , these drugs work by mimicking the body's own substances that regulate blood glucose and encourage weight loss . Though copyright is a commercial product for type 2 diabetes , Semaglutide

Patients struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Prescribed by regulatory bodies for chronic weight management, Semaglutide acts as a